Estimating the value of sodium-glucose cotransporter-2 inhibitors within the context of contemporary guidelines and the totality of evidence.

Phil McEwan,Volker Foos, Becky Martin,Jieling Chen,Marc Evans

Diabetes, obesity & metabolism（2023）

引用 2|浏览7

暂无评分

摘要

Our results show that SGLT2 inhibitors have the potential to lower healthcare costs while improving health outcomes in eligible patient subpopulations.

查看译文

关键词

inhibitors,<scp>sodium‐glucose,<scp>sodium‐glucose

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要